What is it about?
The purpose of this Japan Clinical Oncology Group (JCOG) patient-reported outcome/quality of life research policy is to define patient-reported outcome/health-related quality of life research and provide guidelines for including patient-reported outcome/health-related quality of life as an endpoint in JCOG trials.
Featured Image
Photo by Igor Kasalovic on Unsplash
Why is it important?
This JCOG policy covers minimum requirement and basic knowledge for onclogists on conducting PRO/QOL research in cancer clinical tial.
Perspectives
To prevail PRO/QOL research in cancer clinical trial will result in development of better treatment strategy for cancer patients.
Naomi Kiyota
Kobe University Hospital
Read the Original
This page is a summary of: Patient-reported outcome and quality of life research policy: Japan Clinical Oncology Group (JCOG) policy, Japanese Journal of Clinical Oncology, January 2023, Oxford University Press (OUP),
DOI: 10.1093/jjco/hyad007.
You can read the full text:
Resources
Contributors
The following have contributed to this page
